Mikhail Kosiborod
Mikhail Kosiborod
Saint Luke's Mid America Heart Institute
Verified email at
Cited by
Cited by
Heart disease and stroke statistics—2016 update: a report from the American Heart Association
D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ...
circulation 133 (4), e38-e360, 2016
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American …
JS Skyler, R Bergenstal, RO Bonow, J Buse, P Deedwania, EAM Gale, ...
Circulation 119 (2), 351-357, 2009
Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline
GE Umpierrez, R Hellman, MT Korytkowski, M Kosiborod, GA Maynard, ...
The Journal of Clinical Endocrinology & Metabolism 97 (1), 16-38, 2012
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction
SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ...
New England Journal of Medicine 387 (12), 1089-1098, 2022
Excess mortality among persons with type 2 diabetes
M Tancredi, A Rosengren, AM Svensson, M Kosiborod, A Pivodic, ...
New England Journal of Medicine 373 (18), 1720-1732, 2015
The obesity paradox: body mass index and outcomes in patients with heart failure
JP Curtis, JG Selter, Y Wang, SS Rathore, IS Jovin, F Jadbabaie, ...
Archives of internal medicine 165 (1), 55-61, 2005
Glycemic control and excess mortality in type 1 diabetes
M Lind, AM Svensson, M Kosiborod, S Gudbjörnsdottir, A Pivodic, ...
New England Journal of Medicine 371 (21), 1972-1982, 2014
Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association …
CS Fox, SH Golden, C Anderson, GA Bray, LE Burke, IH De Boer, ...
Circulation 132 (8), 691-718, 2015
Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes
M Kosiborod, SS Rathore, SE Inzucchi, FA Masoudi, Y Wang, ...
Circulation 111 (23), 3078-3086, 2005
Sotagliflozin in patients with diabetes and chronic kidney disease
DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ...
New England Journal of Medicine 384 (2), 129-139, 2021
Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk
M Kosiborod, SE Inzucchi, HM Krumholz, L Xiao, PG Jones, S Fiske, ...
Circulation 117 (8), 1018-1027, 2008
13. Children and Adolescents: Standards of Medical Care in Diabetes—2021
American Diabetes Association
Diabetes care 44 (Supplement_1), S180-S199, 2021
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006
H Bueno, JS Ross, Y Wang, J Chen, MT Vidán, SLT Normand, JP Curtis, ...
Jama 303 (21), 2141-2147, 2010
Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and …
P Deedwania, M Kosiborod, E Barrett, A Ceriello, W Isley, T Mazzone, ...
Circulation 117 (12), 1610-1619, 2008
Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative …
M Kosiborod, MA Cavender, AZ Fu, JP Wilding, K Khunti, RW Holl, ...
Circulation 136 (3), 249-259, 2017
Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry
TT Tsai, UD Patel, TI Chang, KF Kennedy, FA Masoudi, ME Matheny, ...
JACC: Cardiovascular Interventions 7 (1), 1-9, 2014
Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not …
SM Dunlay, MM Givertz, D Aguilar, LA Allen, M Chan, AS Desai, A Deswal, ...
Circulation 140 (7), e294-e324, 2019
The system can't perform the operation now. Try again later.
Articles 1–20